!["Al's superior speed & learning capability make it a natural fit for healthcare tasks demanding precision & early detection" "Al's superior speed & learning capability make it a natural fit for healthcare tasks demanding precision & early detection"](https://cdn.magzter.com/1444374281/1706683223/articles/Hs-u4s8vP1706692691319/ALS-SUPERIOR-SPEED-LEARNING-CAPABILITY-MAKE-IT-A-NATURAL-FIT-FOR-HEALTHCARE-TASKS-DEMANDING-PRECISION-EARLY-DETECTION.jpg)
How did VinBrain come into existence?
After 26 years abroad, spending 13 years as the Director of Engineering and AI Innovation at Microsoft in the United States, I returned to Vietnam. my homeland, in 2019. The founding of VinBrain can be traced back to a series of coincidental events that occurred at that time, nearly five years ago.
Witnessing my mother's stroke firsthand on one back-home occasion made me acutely aware of healthcare challenges in Vietnam. Leaving my 13-year leadership at Microsoft, I answered Vietnam's billionaire, Chair of Vingroup, Pham Nhat Vuong's call to build a global tech alliance with Vietnamese talents, fueled by ‘forever the entrepreneurship spirit’. Consequently, the firm determination of 18 like-minded talents beside me, who bred the seed of VinBrain in 2019, led us on a mission to alleviate patient suffering and relieve the overburdened healthcare workforce through advanced AI technologies. We aspired to build a health tech company where the core technology was developed by Vietnamese talents, breaking away from the conventional practice of importing solutions from overseas. ‘Infuse AI and IoT to improve people's lives and productivity’ is the company's mission to streamline all its efforts and activities and enable diagnostic radiology and digital healthcare transformation to accelerate to the next level of excellence.
What are the key technological advancements that have propelled VinBrain's position as a leader in AI solutions for healthcare?
Bu hikaye BioSpectrum Asia dergisinin BioSpectrum Asia Feb 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye BioSpectrum Asia dergisinin BioSpectrum Asia Feb 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
![Prof. Christian Wolfrum to join NTU as Deputy President and Provost Prof. Christian Wolfrum to join NTU as Deputy President and Provost](https://reseuro.magzter.com/100x125/articles/11639/1979239/aFQSj2cXo1738327652897/PROF-CHRISTIAN-WOLFRUM-TO-JOIN-NTU-AS-DEPUTY-PRESIDENT-AND-PROVOST.jpg)
Prof. Christian Wolfrum to join NTU as Deputy President and Provost
Nanyang Technological University, Singapore (NTU Singapore) has announced that Professor Christian Wolfrum, an eminent biomedical scientist, will be joining the University as the next Deputy President and Provost.
![Japan suggests addition of PVA into drugs for strong antitumour activity Japan suggests addition of PVA into drugs for strong antitumour activity](https://reseuro.magzter.com/100x125/articles/11639/1979239/L7QBK8c9t1738327954522/JAPAN-SUGGESTS-ADDITION-OF-PVA-INTO-DRUGS-FOR-STRONG-ANTITUMOUR-ACTIVITY.jpg)
Japan suggests addition of PVA into drugs for strong antitumour activity
Treatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addition of polyvinyl alcohol (PVA), the same ingredient used in children's glue.
!["Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly" "Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly"](https://reseuro.magzter.com/100x125/articles/11639/1979239/Bh4IoWqD71738326641256/DEMAND-FOR-SKILLED-MEDTECH-PROFESSIONALS-IN-THE-ASIA-PACIFIC-REGION-IS-GROWING-RAPIDLY.jpg)
"Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly"
2024 saw Japanese medtech firm Olympus receiving approval for the company's first cloud-based AI endoscopy devices in the US and Europe, marking a significant milestone in Olympus' efforts to enhance clinical outcomes and operational efficiency in endoscopy, paving the way to launch its upcoming endoscopy solution, the “Intelligent Endoscopy Ecosystem”.
![BeiGene names Giancarlo Benelli as Head of Europe biz BeiGene names Giancarlo Benelli as Head of Europe biz](https://reseuro.magzter.com/100x125/articles/11639/1979239/dtWtyXs321738327727847/BEIGENE-NAMES-GIANCARLO-BENELLI-AS-HEAD-OF-EUROPE-BIZ.jpg)
BeiGene names Giancarlo Benelli as Head of Europe biz
BeiGene, a Hong Kong-headquartered oncology company that intends to change its name to BeOne Medicines Ltd., has announced the appointment of Giancarlo Benelli as Senior Vice President and Head of Europe, effective January 1.
![Korea develops innovative injectable adhesive hydrogel for bone regeneration Korea develops innovative injectable adhesive hydrogel for bone regeneration](https://reseuro.magzter.com/100x125/articles/11639/1979239/3Ds0USfx91738327790862/KOREA-DEVELOPS-INNOVATIVE-INJECTABLE-ADHESIVE-HYDROGEL-FOR-BONE-REGENERATION.jpg)
Korea develops innovative injectable adhesive hydrogel for bone regeneration
A research team from South Korea-based Pohang University of Science and Technology or POSTECH's Department of Chemical Engineering and Graduate School of Convergence Science and Technology, along with the Department of Chemical Engineering, has developed an innovative injectable adhesive hydrogel for bone regeneration.
![When Clinical Trials Suffer From 'Complicated' Interactions When Clinical Trials Suffer From 'Complicated' Interactions](https://reseuro.magzter.com/100x125/articles/11639/1979239/NXkS_2pHM1738327122349/WHEN-CLINICAL-TRIALS-SUFFER-FROM-COMPLICATED-INTERACTIONS.jpg)
When Clinical Trials Suffer From 'Complicated' Interactions
Diversity in culture, language, and data gathering methods will further increase the difficulty of clinical trials as they become more international, particularly with the growing number of sites being employed across China, Japan, South Korea, and India.
![Dr Krishna M Ella receives prestigious INSA India fellowship Dr Krishna M Ella receives prestigious INSA India fellowship](https://reseuro.magzter.com/100x125/articles/11639/1979239/ewbWvQ-3l1738327520276/DR-KRISHNA-M-ELLA-RECEIVES-PRESTIGIOUS-INSA-INDIA-FELLOWSHIP.jpg)
Dr Krishna M Ella receives prestigious INSA India fellowship
Dr Krishna Ella, a distinguished scientist, co-founder and Executive Chairman of Bharat Biotech International, has been recognised with the prestigious India Fellowship of the Indian National Science Academy (INSA) for the year 2025, for his contributions to new knowledge, discoveries, development of new vaccine technologies, noteworthy improvement in existing technologies.
![Bruker launches infrared imaging microscope for pharma and life science research Bruker launches infrared imaging microscope for pharma and life science research](https://reseuro.magzter.com/100x125/articles/11639/1979239/AOv9T23_N1738328062423/BRUKER-LAUNCHES-INFRARED-IMAGING-MICROSCOPE-FOR-PHARMA-AND-LIFE-SCIENCE-RESEARCH.jpg)
Bruker launches infrared imaging microscope for pharma and life science research
US-based Bruker Corporation has announced the launch of the LUMOS II ILIM, a quantum cascade laser (QCL) based infrared (IR) imaging microscope.
![Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities](https://reseuro.magzter.com/100x125/articles/11639/1979239/vrAMheQwA1738328031280/QIAGEN-INCREASES-QIACUITY-DIGITAL-PCR-HIGHORDER-MULTIPLEXING-CAPABILITIES.jpg)
Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities
Qiagen has announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more than two-fold increase in the number of targets that can be simultaneously analysed from a single biological sample.
![Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers](https://reseuro.magzter.com/100x125/articles/11639/1979239/5sZt4mdv41738328195356/REPLIGEN-UNVEILS-ADVANCED-UVBASED-VARIABLE-PATHLENGTH-TECHNOLOGY-SYSTEM-FOR-BIOPHARMA-MANUFACTURERS.jpg)
Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers
US-based Repligen Corporation has announced the commercial launch of its CTech SoloVPE PLUS System, the most advanced UV-based Variable Pathlength Technology system now available to biopharmaceutical manufacturers.